| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |